Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vinayak Bapat

Thoracic Surgery (Cardiothoracic Vascular Surgery) Minneapolis, MN Medical Doctor

NPI 1730617713 CMS profile 3445035

800 E 28Th St # H2100, Minneapolis, MN 55407

Open in the dashboard

General payments

$792,364

878 records reported · program years 2019–2025

Research payments

$81,791

Paid to them · 36 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$184,142 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Vinayak Bapat of Minneapolis, MN is reported in the CMS Open Payments database as having received $792,364 across 878 general payments and $81,791 in research payments paid to them. Separately, studies naming them as principal investigator received $184,142 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $100,580 115
2025 Research $12,288 11
2024 General $386,439 164
2024 Research $23,094 7
2023 General $42,008 106
2023 Research $12,600 2
2022 General $52,598 105
2021 General $78,357 146
2021 Research $16,675 6
2020 General $53,794 85
2020 Research $10,475 6
2019 General $78,588 157
2019 Research $6,659 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vinayak Bapat
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Vinayak Bapat were reported at $100,580. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Vinayak Bapat Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $78,588 $886 $178–$3,167 $163
2020 $53,794 $341 $108–$1,605 $114
2021 $78,357 $453 $125–$1,886 $132
2022 $52,598 $695 $180–$2,566 $149
2023 $42,008 $745 $205–$2,662 $160
2024 $386,439 $799 $214–$2,967 $164
2025 $100,580 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $395,093 239 payments
  2. Abbott Laboratories $174,932 156 payments
  3. Medtronic, Inc. $105,431 289 payments
  4. Medtronic Vascular, Inc. $99,691 126 payments
  5. Boston Scientific Corporation $10,020 35 payments
  6. Atricure, Inc. $3,920 17 payments
  7. Opsens Inc. $1,000 1 payment
  8. ClearFlow, Inc. $751 1 payment
  9. Corcym Inc $634 5 payments
  10. Bard Peripheral Vascular, Inc. $375 1 payment
  11. Other $518 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $307,750 84 payments
  2. Acquisitions $223,082 1 payment
  3. Travel and Lodging $123,372 260 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $99,106 19 payments
  5. Food and Beverage $33,537 510 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $4,875 2 payments
  7. Honoraria $575 1 payment
  8. Grant $66 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $103,469 66 payments
  2. NAVITOR Vascular $58,519 29 payments
  3. CoreValve Evolut $45,637 54 payments
  4. NAVITOR Structural Heart $41,220 19 payments
  5. COREVALVE EVOLUT R $40,826 68 payments
  6. JETI ALL IN ONE NON-STERILE KIT $15,622 2 payments
  7. EPIC $13,272 19 payments
  8. PORTICO $11,913 27 payments
  9. Edwards SAPIEN 3 Transcatheter Heart Valve $10,658 41 payments
  10. Avalus $8,089 16 payments
  11. Other $54,331 201 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $64,656 26 payments
  2. Medtronic Vascular, Inc. $17,134 10 payments

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$57,103

Medicare's payments for the services billed

Medicare patients

59

Average age 76

Services billed

104

28 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Heart failure 58%
Atrial fibrillation 58%
Ischemic heart disease 54%
Arthritis 41%
Chronic kidney disease 39%
Diabetes 32%
Cancer 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

914 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record